The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

The CDC drew widespread criticism for updating its website with language suggesting a possible link between vaccines and ...

Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The ...

Ostro’s effort to boost the country’s less-than-stellar health literacy earned the startup a place in the Guinness World Records this week. The company’s virtual course now holds the record for the ...

Sanofi has reached a deal to acquire all of biologics drug developer Inhibrx, but the pharmaceutical giant will keep just a single drug candidate. The rest of Inhibrx’s assets will be spun off into a ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...

National health system Ardent Health Services recently announced they have rolled out a new health benefits offering to 23,000 Ardent employees and their dependents. The offering stems from an ...

A new study found that a non-invasive, AI enabled Coronary Computer Tomography Angiography effectively identified stenosis equally well or better than the conventional gold standard of invasive ...

Pyx Health, a healthcare member activation company, launched a new platform on Monday to support care navigation and make it easier for people to access healthcare resources. Tucson, Arizona-based Pyx ...

CVS Caremark, Express Scripts and Optum Rx are fighting back. After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of engaging in anticompetitive rebating ...

Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal to acquire Regulus Therapeutics, a biotech with a drug ready for pivotal testing in a rare ...